S. Maletic

Evaluation of the economic impact of modified screening criteria for retinopathy of prematurity from the Postnatal Growth and ROP (G-ROP) Study

David L. Rogers, Jingyun Wang, J. Zupancic, 2020, Journal of Perinatology.

Plasma Levels of Bevacizumab and Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity in Infants.

David L. Rogers, D. Coats, A. Hutchinson, 2022, JAMA ophthalmology.